- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Seelos Therapeutics is a biotechnology business based in the US. Seelos Therapeutics shares (SEEL) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $1.22 – an increase of 1.67% over the previous week. Seelos Therapeutics employs 8 staff and has a trailing 12-month revenue of around $2 million.
What's in this guide?
- SEEL shares summary
- Compare share dealing platforms
- Is SEEL stock a buy or sell?
- Stock performance over time
- Can I short SEEL shares?
- Are SEEL shares over-valued?
- Seelos Therapeutics's financials
- How volatile are SEEL shares?
- Does Seelos Therapeutics pay a dividend?
- Have SEEL shares ever split?
- Other common questions
Our top picks for where to buy Seelos Therapeutics stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Seelos Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SEEL. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Seelos Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Seelos Therapeutics stock price (OTCQB: SEEL)
Use our graph to track the performance of SEEL stocks over time.Seelos Therapeutics shares at a glance
Information last updated 2024-10-23.
| Latest market close | $1.22 |
|---|---|
| 52-week range | $0.82 - $789.12 |
| 50-day moving average | $3.54 |
| 200-day moving average | $48.55 |
| Wall St. target price | $120.00 |
| PE ratio | 0.0033 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $351.04 |
Is it a good time to buy Seelos Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Seelos Therapeutics price performance over time
Historical closes compared with the close of $1.22 from 2024-10-25
| 1 week (2024-10-22) | 1.67% |
|---|---|
| 1 month (2024-09-27) | -68.72% |
| 3 months (2024-07-29) | 185.05% |
| 6 months (2024-04-29) | 335.25% |
| 1 year (2023-10-27) | 480.95% |
|---|---|
| 2 years (2022-10-28) | 39.36% |
| 3 years (2021-10-29) | 2.16 |
| 5 years (2019-10-29) | 33.92% |
Is Seelos Therapeutics stock undervalued or overvalued?
Valuing Seelos Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Seelos Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Seelos Therapeutics's P/E ratio
Seelos Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Seelos Therapeutics shares trade at around 0x recent earnings.
Seelos Therapeutics financials
| Revenue TTM | $2 million |
|---|---|
| Gross profit TTM | $-46,649,000 |
| Return on assets TTM | -261.11% |
| Return on equity TTM | -584.2% |
| Profit margin | 203.13% |
| Book value | $-135.50 |
| Market Capitalization | $668,150 |
TTM: trailing 12 months
Seelos Therapeutics share dividends
We're not expecting Seelos Therapeutics to pay a dividend over the next 12 months.
Have Seelos Therapeutics's shares ever split?
Seelos Therapeutics's shares were split on a 1:16 basis on 26 September 2024 . So if you had owned 16 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Seelos Therapeutics shares – just the quantity. However, indirectly, the new 1500% higher share price could have impacted the market appetite for Seelos Therapeutics shares which in turn could have impacted Seelos Therapeutics's share price.
Seelos Therapeutics share price volatility
Over the last 12 months, Seelos Therapeutics's shares have ranged in value from as little as $0.82 up to $789.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Seelos Therapeutics's is 1.851. This would suggest that Seelos Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Seelos Therapeutics overview
Seelos Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-004, an gene therapy targeting gene and alpha synuclein; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; SLS-007, a peptidic inhibitor for NACore Parkinson disease; and SLS-009, a protein targeted autophagy for Alzheimer disease. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York. .
Frequently asked questions
What percentage of Seelos Therapeutics is owned by insiders or institutions?Currently 0.491% of Seelos Therapeutics shares are held by insiders and 3.697% by institutions. How many people work for Seelos Therapeutics?
Latest data suggests 8 work at Seelos Therapeutics. When does the fiscal year end for Seelos Therapeutics?
Seelos Therapeutics's fiscal year ends in December. Where is Seelos Therapeutics based?
Seelos Therapeutics's address is: 300 Park Avenue, New York, NY, United States, 10022 What is Seelos Therapeutics's ISIN number?
Seelos Therapeutics's international securities identification number is: US81577F1093 What is Seelos Therapeutics's CUSIP number?
Seelos Therapeutics's Committee on Uniform Securities Identification Procedures number is: 652903105
More resources on Finder
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Moderna stock (MRNA)
Steps to owning and managing MRNA, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question